Curative, a Texas-based health insurance startup focused on reducing employer healthcare expenses, has raised more than $150 million, lifting its valuation to approximately $1.28 billion. The company aims to curb rising insurance costs, driven by inflation, expensive medications, and chronic illnesses, by removing copays and deductibles for in-network care, provided members complete an annual primary-care visit with a clinician and a care “navigator.”
CEO Fred Turner said, “We think the only number that you can make sure all of your employees genuinely remember for what it is going to cost to seek care is zero.” He added that early treatment of conditions such as diabetes, hypertension, and cancer can prevent far more expensive interventions later. Curative reports that 98% of its members complete their annual check-ups, avoiding the alternative deductible of up to $5,000 for individuals and $10,000 for families.
The company covers 165,000 members across 1,200 employers in Texas, Florida, and Georgia, with plans to expand to Washington, D.C., and Maryland. Its model contrasts with traditional plans that have raised deductibles, which averaged $1,886 for individual coverage this year. Curative projects $570 million in revenue for 2026 and expects its first post-pandemic profit the same year. The latest funding round was led by TED Conferences Chairman Chris Anderson through the Upside Vision Fund, with participation from Michael Novogratz, Stanley Druckenmiller’s Duquesne Family Office, DCVC, Martin Varsavsky, and Justin Mateen, who said, “We have a massive market that no one is really happy with.”
